This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwon, D. H.
Right arrow Articles by Graham, D. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwon, D. H.
Right arrow Articles by Graham, D. Y.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2003, p. 2169-2178, Vol. 47, No. 7
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.7.2169-2178.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

High-Level ß-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori

Dong H. Kwon,1* M. P. Dore,2 J. J. Kim,3 M. Kato,4 M. Lee,5 J. Y. Wu,1 and D. Y. Graham1,6

Veterans Affairs Medical Center and Departments of Medicine,1 Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030,6 Department of Internal Medicine, University of Sassari, Sassari, Italy,2 Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine,3 Department of Clinical Pathology, Ewha Women's University Mokdong Hospital, Seoul, Korea,5 Department of Endoscopy, Hokkaido University School of Medicine, Sapporo, Japan4

Received 16 October 2002/ Returned for modification 17 January 2003/ Accepted 20 April 2003

Four clinical Helicobacter pylori isolates with high-level resistance to ß-lactams exhibited low- to moderate-level resistance to the structurally and functionally unrelated antibiotics ciprofloxacin, chloramphenicol, metronidazole, rifampin, and tetracycline. This pattern of multidrug resistance was transferable to susceptible H. pylori by natural transformation using naked genomic DNA from a clinical multidrug-resistant isolate. Acquisition of the multidrug resistance was also associated with a change in the genotype of the transformed multidrug-resistant H. pylori. DNA sequence analyses of the gene encoding penicillin binding protein 1A (PBP 1A) showed 36 nucleotide substitutions resulting in 10 amino acid changes in the C-terminal portion (the putative penicillin binding domain). Acquisition of ß-lactam resistance was consistently associated with transfer of a mosaic block containing the C-terminal portion of PBP 1A. No changes of genes gyrA, rpoB, rrn16S, rdxA, and frxA, and nine other genes (ftsI, hcpA, llm, lytB, mreB, mreC, pbp2, pbp4, and rodA1) encoding putative PBPs or involved in cell wall synthesis were found among the transformed resistant H. pylori. Antibiotic accumulations of chloramphenicol, penicillin, and tetracycline were all significantly decreased in the natural and transformed resistant H. pylori compared to what was seen with susceptible H. pylori. Natural transformation also resulted in the outer membrane protein profiles of the transformed resistant H. pylori becoming similar to that of the clinical resistant H. pylori isolates. Overall, these results demonstrate that high-level ß-lactam resistance associated with acquired multidrug resistance in clinical H. pylori is mediated by combination strategies including alterations of PBP 1A and decreased membrane permeability.

* Corresponding author. Mailing address: Veterans Affairs Medical Center (111D), 2002 Holcombe Blvd., Houston, Texas 77030. Phone: (713) 794-7801. Fax: (713) 795-4471. E-mail: dkwon{at}bcm.tmc.edu.

Antimicrobial Agents and Chemotherapy, July 2003, p. 2169-2178, Vol. 47, No. 7
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.7.2169-2178.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Boyanova, L. (2009). Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria. J Med Microbiol 58: 930-935 [Abstract] [Full Text]  
  • Rimbara, E., Noguchi, N., Kawai, T., Sasatsu, M. (2008). Mutations in penicillin-binding proteins 1, 2 and 3 are responsible for amoxicillin resistance in Helicobacter pylori. J Antimicrob Chemother 61: 995-998 [Abstract] [Full Text]  
  • Co, E.-M. A., Schiller, N. L. (2006). Resistance Mechanisms in an In Vitro-Selected Amoxicillin-Resistant Strain of Helicobacter pylori. Antimicrob. Agents Chemother. 50: 4174-4176 [Abstract] [Full Text]  
  • Boyanova, L., Nikolov, R., Lazarova, E., Gergova, G., Katsarov, N., Kamburov, V., Spassova, Z., Derejian, S., Jelev, C., Mitov, I., Krastev, Z. (2006). Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adult patients over 9 years. J Med Microbiol 55: 65-68 [Abstract] [Full Text]  
  • Wu, J. Y., Kim, J. J., Reddy, R., Wang, W. M., Graham, D. Y., Kwon, D. H. (2005). Tetracycline-Resistant Clinical Helicobacter pylori Isolates with and without Mutations in 16S rRNA-Encoding Genes. Antimicrob. Agents Chemother. 49: 578-583 [Abstract] [Full Text]  
  • Megraud, F (2004). H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53: 1374-1384 [Full Text]  
  • Falsafi, T., Mobasheri, F., Nariman, F., Najafi, M. (2004). Susceptibilities to Different Antibiotics of Helicobacter pylori Strains Isolated from Patients at the Pediatric Medical Center of Tehran, Iran. J. Clin. Microbiol. 42: 387-389 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»